Page 5 - Sohini Das

Non-animal testing can cut drug costs by up to 90%, says report

Dr Reddy's, Biocon and Sun Pharma are exploring human-based testing methods that could halve drug development timelines and sharply reduce costs, while meeting global regulatory standards

Emcure Q3 results: PAT jumps 48% as India, overseas revenues surge

Pune-based Emcure Pharma posted strong Q3 FY26 results on double-digit domestic and international growth, as it eyes entry into India's top 10 drugmakers

Tariff reset lifts India's medical device pulse amid China+1 shift

For Indian medical device exporters, the tariff reset addresses a long-standing vulnerability: wafer-thin margins

US-India tariff reset lifts engineering exports; auto components lead gains

India's engineering exports to the US are set to regain momentum after reciprocal tariffs were cut to 18%, with auto component makers expected to benefit the most

US tariff cut likely to benefit Indian auto component makers more than OEMs

Brokerages and industry bodies say easing US reciprocal tariffs to 18% will materially boost competitiveness and exports of Indian auto component makers, while gains for vehicle OEMs remain limited

Sun Pharma sees US generics stabilising, pins growth on innovation push

Sun Pharmaceutical Industries expects pressure on its US generics business to ease as compliance improves, while focusing growth efforts on innovation-led therapies

Union Budget 2026-27: Over ₹1 trillion earmarked for the nation's health

Biopharma Shakti initiative to tackle burden of non-communicable diseases, turn India into global, innovation-led hub

Budget 2026: Biopharma to medical tourism, push for healthcare value chain

In Union Budget 2026, FM Nirmala Sitharaman announces ₹10,000 cr Mission Biopharma Shakti, 1,000 clinical trial sites, 10,000 new medical seats, Customs relief on key drugs, and 5 medical tourism hubs

Jeep places India at centre of Asia-Pacific strategy under Jeep 2.0 plan

Jeep outlines a renewed regional roadmap with higher localisation, export expansion and focus on products and ownership experience amid intense competition in India's SUV market

India leads but China narrows gap in South Africa's passenger vehicle track

China-assembled cars have doubled their share of the market

One-time costs drag down Tata Motors CV's profit, wholesales rise 20%

Revenue for the quarter increased 16.1 per cent to ₹21,847 crore.

Maruti Suzuki India's quarterly sales hit record as small cars roar

PAT grows 4% YoY impacted by one-time provision of ₹593 cr on account of the New Labour Codes

India-EU trade deal: Auto firms eye India to take on Chinese rivals

Look to use India's manufacturing cost advantage as carmakers from China have gained market share in EU in recent years

India-EU trade deal likely to help GLP-1 therapies become cheaper

India-EU FTA to lower tariffs on pharma, potentially making GLP-1 therapies like semaglutide cheaper and boosting adoption among diabetics in India

VinGroup's GSM to pit ownership-first e-taxis against Ola, Uber

Vietnam's largest e-taxi operator plans 5-city rollout with VinFast cars

Q3FY26 preview: Strong domestic sales to lift revenues for pharma firms

Strong domestic sales are expected to lift Q3FY26 pharma revenues by 8-11%, while US generic Revlimid impacts weigh on margins. Hospitals and diagnostics outperform, with 20-22% revenue growth

Q3 Preview: Strong domestic sales set to lift pharma revenues by up to 11%

Strong domestic demand is set to lift pharma revenues by up to 11% in Q3FY26, though pressure from generic Revlimid in the US may limit profit growth

Q3FY26 auto sector preview: Festive demand, GST cuts to lift earnings

Festive-led demand, GST rationalisation, easing rates and operating leverage are expected to drive strong revenue and profit growth for auto OEMs and ancillaries in Q3FY26

Bajaj Auto plans to take Chetak EV scooters to over 100 countries

Bajaj Auto is planning a phased expansion of its Chetak electric scooter to over 100 countries, focusing on localisation and its global distributor network rather than an aggressive rollout

Changing gears: Mercedes-Benz turns growth wheel towards ultra-luxury

Despite a 2.8 per cent fall in 2025 volumes, Mercedes-Benz India reported its best-ever revenue and profitability, led by top-end models, AMG growth and higher BEV mix